EARLY BREAST CANCER
Clinical trials for EARLY BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new EARLY BREAST CANCER trials appear
Sign up with your email to follow new studies for EARLY BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Breast cancer patients may prefer treatment at home
Symptom relief CompletedThis study looked at whether people with HER2-positive breast cancer prefer getting their medication at home or in the hospital. 346 participants received a combination of two drugs (pertuzumab and trastuzumab) as a shot under the skin. The main goal was to see which setting they…
Matched conditions: EARLY BREAST CANCER
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Symptom relief
Last updated May 22, 2026 14:01 UTC
-
Immune cells in breast tumors may predict Long-Term survival
Knowledge-focused CompletedThis study looked at immune cells (called TILs and CD8+ T cells) in tumor samples from over 3,600 women with early-stage breast cancer who had chemotherapy after surgery. The goal was to see if these cells are linked to how long patients live without the cancer coming back. The f…
Matched conditions: EARLY BREAST CANCER
Sponsor: Hellenic Cooperative Oncology Group • Aim: Knowledge-focused
Last updated May 26, 2026 03:56 UTC
-
Hormone Therapy's hidden toll: skin issues plague breast cancer survivors
Knowledge-focused CompletedThis study measured how skin problems caused by hormone therapy impact the daily lives of women with early breast cancer. Researchers surveyed 155 women from several European countries who had been on hormone therapy for 2-3 years. The women completed questionnaires about their s…
Matched conditions: EARLY BREAST CANCER
Sponsor: Pierre Fabre Medicament • Aim: Knowledge-focused
Last updated May 26, 2026 03:54 UTC
-
Immune clues in breast tumors may predict chemo success
Knowledge-focused CompletedThis study looked at 171 women with early breast cancer to see if immune cells inside tumors are linked to how well chemotherapy works. Researchers also checked if these immune markers relate to cancer DNA in the blood. The goal is to better understand which patients might respon…
Matched conditions: EARLY BREAST CANCER
Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated May 18, 2026 12:10 UTC